| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains
|
Jack van Horssen
|
|
2004
|
|
5 |
p. 469-474
|
artikel
|
| 2 |
A latent variable model approach for assembling and scoring screening tests for dementia
|
Jianzhao Shen
|
|
2003
|
|
5 |
p. 399-407
|
artikel
|
| 3 |
Alzheimer Award
|
|
|
2004
|
|
5 |
p. 571
|
artikel
|
| 4 |
Alzheimer's Disease: A Compendium of Current Theories, Annals of the New York Academy of Sciences, Volume 924, Zaven S. Khachaturian and M. Marsel Mesulam, eds
|
Marcelle Morrison-Bogorad
|
|
2001
|
|
5 |
p. 519-520
|
artikel
|
| 5 |
Alzheimer's disease-related synapse loss in the cingulate cortex
|
Stephen W. Scheff
|
|
2001
|
|
5 |
p. 495-505
|
artikel
|
| 6 |
Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor
|
Ling, Xie
|
|
2002
|
|
5 |
p. 369-374
|
artikel
|
| 7 |
Amyloid-β promotes calcium influx and neurodegeneration via stimulation of L voltage-sensitive calcium channels rather than NMDA channels in cultured neurons
|
Ho, Rebecca
|
|
2001
|
|
5 |
p. 479-483
|
artikel
|
| 8 |
Aplipoprotein E genotyping: accurate, simple, high throughput method using ABI Prism® SNaPshot™ Multiplex System
|
Liat Ben-Avi
|
|
2004
|
|
5 |
p. 497-501
|
artikel
|
| 9 |
Apolipoprotein E and mortality in African-Americans and Yoruba
|
Lane, Kathleen A.
|
|
2003
|
|
5 |
p. 383-390
|
artikel
|
| 10 |
Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Aß deposition, in an AßPP/PS double transgenic mouse model of Alzheimer's disease
|
David A. Costa
|
|
2004
|
|
5 |
p. 509-514
|
artikel
|
| 11 |
AβPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576
|
Otth, Carola
|
|
2002
|
|
5 |
p. 417-430
|
artikel
|
| 12 |
A quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer's diseased brain
|
Goux, Warren J.
|
|
2001
|
|
5 |
p. 455-466
|
artikel
|
| 13 |
Axonal transport hypothesis moves on to implicate presenilin: Alzheimer research forum live discussion
|
|
|
2004
|
|
5 |
p. 537-545
|
artikel
|
| 14 |
Characterization by atomic force microscopy and cryoelectron microscopy of tau polymers assembled in Alzheimer's disease
|
Fernando Moreno-Herrero
|
|
2001
|
|
5 |
p. 443-451
|
artikel
|
| 15 |
Characterization of the human α-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms
|
Xia, Yu
|
|
2001
|
|
5 |
p. 485-494
|
artikel
|
| 16 |
Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease
|
Small, David H.
|
|
2002
|
|
5 |
p. 349-355
|
artikel
|
| 17 |
Commentary Commentary on: The Characterization by Atomic Force Microscopy and Cryoelectron Microscopy of Tau Polymers assembled in Alzheimer's disease
|
George C. Ruben
|
|
2001
|
|
5 |
p. 453-454
|
artikel
|
| 18 |
Designing a Brief Alzheimer Screen (BAS)
|
Marta S. Mendiondo
|
|
2003
|
|
5 |
p. 391-398
|
artikel
|
| 19 |
Design of the Chicago Health and Aging Project (CHAP)
|
Julia L. Bienias
|
|
2003
|
|
5 |
p. 349-355
|
artikel
|
| 20 |
Development of a safe oral Aß vaccine using recombinant adeno-associated virus vector for Alzheimer's disease
|
Hideo Hara
|
|
2004
|
|
5 |
p. 483-488
|
artikel
|
| 21 |
From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: The role of NSAIDs and cyclooxygenase in β-amyloidosis and clinical dementia
|
Pasinetti, Giulio Maria
|
|
2002
|
|
5 |
p. 435-445
|
artikel
|
| 22 |
Hypothesis testing of a change point during cognitive decline among Alzheimer's disease patients
|
Ming Ji
|
|
2003
|
|
5 |
p. 375-382
|
artikel
|
| 23 |
Interaction of Alzheimer's disease amyloid ß peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain
|
Mar Pérez
|
|
2004
|
|
5 |
p. 461-467
|
artikel
|
| 24 |
Is hemochromatosis a risk factor for Alzheimer's disease?
|
Connor, J.R.
|
|
2001
|
|
5 |
p. 471-477
|
artikel
|
| 25 |
Molecular profiling of paired helical filaments Commentary on: Quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer's diseased brain by Warren J. Goux, Bingcam Liu, Abdurahman M. Shumbu
|
Shu G. Chen
|
|
2001
|
|
5 |
p. 467-469
|
artikel
|
| 26 |
Multivariate modeling of two associated cognitive outcomes in a longitudinal study
|
Danielle J. Harvey
|
|
2003
|
|
5 |
p. 357-365
|
artikel
|
| 27 |
Nicotine lowers the secretion of the Alzheimer's amyloid β-protein precursor that contains amyloid β-peptide in rat
|
Utsuki, Tadanobu
|
|
2002
|
|
5 |
p. 405-415
|
artikel
|
| 28 |
Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke
|
A-M. Lidström
|
|
2001
|
|
5 |
p. 435-442
|
artikel
|
| 29 |
Of mice and men: The relevance of transgenic mice Aß immunizations to Alzheimer's disease
|
Alex E. Roher
|
|
2002
|
|
5 |
p. 431-434
|
artikel
|
| 30 |
Pathological and clinical heterogeneity of presenilin 1 gene mutations
|
Manuel Menéndez
|
|
2004
|
|
5 |
p. 475-482
|
artikel
|
| 31 |
Proceedings of the 11th International Symposium, "New Frontiers of Neurochemistry and Neurophysics on Diagnosis and Treatment of Neurological Diseases"
|
Dusan Dobrota
|
|
2004
|
|
5 |
p. 547-568
|
artikel
|
| 32 |
Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation
|
Marina P. Sánchez
|
|
2002
|
|
5 |
p. 399-404
|
artikel
|
| 33 |
Psychiatry Highlights 2003-2004 Fast Facts Series, by Malcolm Lader
|
Alexandre Valério de Mendonça
|
|
2004
|
|
5 |
p. 569
|
artikel
|
| 34 |
Regulation of amyloid β-peptide levels by enzymatic degradation
|
Mukherjee, Atish
|
|
2002
|
|
5 |
p. 341-348
|
artikel
|
| 35 |
Reversible dementia: A case of cryptococcal meningitis masquerading as Alzheimer's disease
|
Thomas A. Ala
|
|
2004
|
|
5 |
p. 503-508
|
artikel
|
| 36 |
Rodent Aß(1-42) exhibits oxidative stress properties similar to those of human Aß(1-42): Implications for proposed mechanisms of toxicity
|
Debra Boyd-Kimball
|
|
2004
|
|
5 |
p. 515-525
|
artikel
|
| 37 |
Serum p97 levels as an aid to identifying Alzheimer's disease
|
H. Feldman
|
|
2001
|
|
5 |
p. 507-516
|
artikel
|
| 38 |
Special Care Units: Research and Practice in Alzheimer's Disease, D. Holmes, J.A. Teresi and M. Ory, eds
|
Carlos Garcia
|
|
2001
|
|
5 |
p. 517-518
|
artikel
|
| 39 |
Tau, where are we now?
|
Johnson, Gail V.W.
|
|
2002
|
|
5 |
p. 375-398
|
artikel
|
| 40 |
The degradation of Aβ25-35 by the serine protease plasmin is inhibited by aluminium
|
Korchazhkina, Olga V.
|
|
2002
|
|
5 |
p. 357-367
|
artikel
|
| 41 |
The potential role of tau protein O-glycosylation in Alzheimer's disease
|
Laura A. Robertson
|
|
2004
|
|
5 |
p. 489-495
|
artikel
|
| 42 |
Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons
|
LuGuang Luo
|
|
2004
|
|
5 |
p. 527-536
|
artikel
|
| 43 |
Upcoming Meetings Related to Alzheimer's Disease
|
|
|
2002
|
|
5 |
p. 447
|
artikel
|
| 44 |
Upcoming meetings related to Alzheimer's disease
|
|
|
2003
|
|
5 |
p. 419-421
|
artikel
|
| 45 |
Upcoming Meetings Related to Alzheimer's Disease
|
|
|
2004
|
|
5 |
p. 573-575
|
artikel
|
| 46 |
Using a Rasch scale to characterize the clinical features of patients with a clinical diagnosis of uncertain, probable, or possible Alzheimer disease at intake
|
Larry F. Hughes
|
|
2003
|
|
5 |
p. 367-373
|
artikel
|
Tijdschrift beschrijving